BriaCell Therapeutics Corp.
NASDAQ: BCTXW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- William V. Williams
- Employees
- 16
- Headquarters
- West Vancouver, Canada
- IPO year
- 2012
- Market cap
- $1.7K
- Website
- https://briacell.com
Loading BCTXW…
Loading profile data…Frequently asked questions about BCTXW
What does BriaCell Therapeutics Corp. (BCTXW) do?
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, currently in Phase 3, dedicated to revolutionizing cancer treatment through its innovative cellular immunotherapies. Its flagship product, Bria-IMT, is currently undergoing a pivotal Phase 3 clinical trial for advanced breast cancer, where it's being evaluated in combination...
Where does BCTXW trade?
BriaCell Therapeutics Corp. (BCTXW) trades on the NASDAQ Capital Market.
What sector is BCTXW in?
BriaCell Therapeutics Corp. (BCTXW) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of BriaCell Therapeutics Corp.?
William V. Williams is the chief executive officer of BriaCell Therapeutics Corp. (BCTXW).
Where is BriaCell Therapeutics Corp. headquartered?
BriaCell Therapeutics Corp. is headquartered in Canada.
Does BCTXW pay a dividend?
BriaCell Therapeutics Corp. (BCTXW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BCTXW go public?
BriaCell Therapeutics Corp. (BCTXW) completed its initial public offering in 2012.